Penserra Capital Management’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-1,790
| Closed | -$18K | – | 1269 |
|
2023
Q3 | $18K | Sell |
1,790
-2,665
| -60% | -$26.8K | ﹤0.01% | 1056 |
|
2023
Q2 | $70K | Buy |
4,455
+1,412
| +46% | +$22.2K | ﹤0.01% | 1003 |
|
2023
Q1 | $68K | Buy |
3,043
+223
| +8% | +$4.98K | ﹤0.01% | 819 |
|
2022
Q4 | $100K | Sell |
2,820
-453
| -14% | -$16.1K | ﹤0.01% | 811 |
|
2022
Q3 | $127K | Buy |
3,273
+2,692
| +463% | +$104K | ﹤0.01% | 707 |
|
2022
Q2 | $27K | Buy |
581
+59
| +11% | +$2.74K | ﹤0.01% | 1051 |
|
2022
Q1 | $48K | Buy |
+522
| New | +$48K | ﹤0.01% | 1007 |
|
2021
Q4 | – | Sell |
-45
| Closed | -$15K | – | 1413 |
|
2021
Q3 | $15K | Buy |
45
+1
| +2% | +$333 | ﹤0.01% | 1292 |
|
2021
Q2 | $16K | Buy |
44
+4
| +10% | +$1.46K | ﹤0.01% | 1197 |
|
2021
Q1 | $12K | Hold |
40
| – | – | ﹤0.01% | 1013 |
|
2020
Q4 | $10K | Buy |
40
+25
| +167% | +$6.25K | ﹤0.01% | 922 |
|
2020
Q3 | $2K | Buy |
+15
| New | +$2K | ﹤0.01% | 907 |
|